Captrust Financial Advisors »

An2 Therapeutics shares owned by Captrust Financial Advisors

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Captrust Financial Advisors from 13F filings

Historical chart of Captrust Financial Advisors investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Captrust Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $51k 40k 1.27
2025-06-30 $42k 40k 1.06
2025-03-31 $14k 10k 1.36
2024-12-31 $40k 29k 1.38
2024-09-30 $31k 29k 1.07
2024-06-30 $62k 29k 2.15
2024-03-31 $93k 29k 3.25
2023-12-31 $587k 29k 20.49
2023-09-30 $461k 29k 16.08